Renaissance Technologies’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
KCM
RHJA
PHP
Renaissance Technologies's OPRX Position: Q2 2026 in Review
Renaissance Technologies reduced its OptimizeRx (OPRX) stake by 23% in Q2 2026, selling an estimated $283K and leaving 167,700 shares worth $959K. The position accounts for ﹤0.01% of the portfolio, ranked #2330.
Renaissance Technologies first reported a position in OPRX in Q2 2019 and has held it in 17 quarters since. The position peaked at $3.39M in Q1 2022. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.
- Renaissance Technologies held 167,700 shares of OptimizeRx worth $959K as of Q2 2026.
- Renaissance Technologies sold 49,156 OptimizeRx shares in Q2 2026, an estimated $283K.
- OptimizeRx made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2330 holding.
- Renaissance Technologies first reported a position in OptimizeRx in Q2 2019 and has held it in 17 quarters since.
- Renaissance Technologies's OptimizeRx position peaked at $3.39M in Q1 2022.
- 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.